Life sciences news

OXURION completes patient enrollment for Part A of Phase 2 study evaluating THR-149 for treatment of Diabetic Macular Edema (DME)

Tuesday June 8th 2021

Read more
SELECTION study on filgotinib in ulcerative colitis published in The Lancet

Friday June 4th 2021

Read more
RheaVita closes EUR 2.5 million Series A Financing co-led by Novalis Biotech Acceleration and PMV

Wednesday June 2nd 2021

Read more
argenx appoints Karl Gubitz as Chief Financial Officer

Wednesday June 2nd 2021

Read more
Sequana Medical announces first patient enrolled in SAHARA DESERT

Tuesday June 1st 2021

Read more
QbD Software announces major rebranding: Scilife is born

Thursday May 27th 2021

Read more
Nextstellis® receives FDA marketing exclusivity and phase III data published

Thursday May 27th 2021

Read more
Mithra announces European approval of Estelle®

Friday May 21st 2021

Read more
Your news here?

Become a flanders.bio member
Investment in Flow Cytometry unlocks the secrets of single cells

Thursday May 20th 2021

Read more
reMYND announces Clinical Advisory Board to support development of Alzheimer’s programme

Thursday May 20th 2021

Read more
Eurofins Genomics meets global demand for SARS-CoV-2 full genome sequencing, with over 100,000 sequenced samples in less than 8 weeks

Thursday May 20th 2021

Read more

More info?

Communication Coordinator